Details of the Drug Reposition

General Information of This Drug (ID: DMNNDMA)

Drug Name	Telomelysin DMNNDMA

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)

2 Phase 2 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Melanoma	DIS1RRCY	2C30	Phase 2	[1]
Merkel cell carcinoma	DISDJJ4U	2C34	Phase 2	[1]
------------------------------------------------------------------------------------

References

1	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)